Stent
12
3
4
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
85.7%
-0.8% vs benchmark
8%
1 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT
Double Stent for Biliary Stones in Cirrhotic Patients
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
Wingspan Stent System for Intracranial Artery Stenosis
Intracoronary Optical Coherence Tomography Guidance Vs. Angiography Only Guidance for Treatment of Coronary In-stent Restenosis
Influence of Calcium Pattern on Plaque Modification Achieved With Intracoronary Lithotripsy
Culprit-first in Primary Percutaneous Coronary Intervention
Effects of a Hybrid Model of Cardiac Rehabilitation on Patient Outcomes
Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
Propel Stent vs Kenalog-soaked Nasopore After Frontal Drill-out
MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction